BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 15125311)

  • 1. [Role of endogenous cannabinoids in cerebral reward mechanisms].
    Wenger T; Fürst S
    Neuropsychopharmacol Hung; 2004 Mar; 6(1):26-9. PubMed ID: 15125311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacology of cannabinoid receptors and their ligands: an overview.
    Pertwee RG
    Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S13-8. PubMed ID: 16570099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The endogenous cardiac cannabinoid system: a new protective mechanism against myocardial ischemia.
    Lamontagne D; Lépicier P; Lagneux C; Bouchard JF
    Arch Mal Coeur Vaiss; 2006 Mar; 99(3):242-6. PubMed ID: 16618028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid signalling in the enteric nervous system.
    Galligan JJ
    Neurogastroenterol Motil; 2009 Sep; 21(9):899-902. PubMed ID: 19689654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of exogenous and endogenous cannabinoids on GABAergic neurotransmission between the caudate-putamen and the globus pallidus in the mouse.
    Engler B; Freiman I; Urbanski M; Szabo B
    J Pharmacol Exp Ther; 2006 Feb; 316(2):608-17. PubMed ID: 16214880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid (CB(1)), GABA(A) and GABA(B) receptor subunit changes in the globus pallidus in Huntington's disease.
    Allen KL; Waldvogel HJ; Glass M; Faull RL
    J Chem Neuroanat; 2009 Jul; 37(4):266-81. PubMed ID: 19481011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of dopamine receptor and neuropeptide expression in the basal ganglia of monkeys treated with MPTP.
    Betarbet R; Greenamyre JT
    Exp Neurol; 2004 Oct; 189(2):393-403. PubMed ID: 15380489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the field of cannabinoid--opioid cross-talk.
    Robledo P; Berrendero F; Ozaita A; Maldonado R
    Addict Biol; 2008 Jun; 13(2):213-24. PubMed ID: 18482431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motor actions of cannabinoids in the basal ganglia output nuclei.
    Sañudo-Peña MC; Tsou K; Walker JM
    Life Sci; 1999; 65(6-7):703-13. PubMed ID: 10462071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of endogenous cannabinoids in synaptic signaling.
    Freund TF; Katona I; Piomelli D
    Physiol Rev; 2003 Jul; 83(3):1017-66. PubMed ID: 12843414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing.
    Wright K; Rooney N; Feeney M; Tate J; Robertson D; Welham M; Ward S
    Gastroenterology; 2005 Aug; 129(2):437-53. PubMed ID: 16083701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presynaptic modulation by endocannabinoids.
    Lovinger DM
    Handb Exp Pharmacol; 2008; (184):435-77. PubMed ID: 18064422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroanatomical relationship between type 1 cannabinoid receptors and dopaminergic systems in the rat basal ganglia.
    Julian MD; Martin AB; Cuellar B; Rodriguez De Fonseca F; Navarro M; Moratalla R; Garcia-Segura LM
    Neuroscience; 2003; 119(1):309-18. PubMed ID: 12763090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Striatal and extrastriatal dopamine in the basal ganglia: an overview of its anatomical organization in normal and Parkinsonian brains.
    Smith Y; Villalba R
    Mov Disord; 2008; 23 Suppl 3():S534-47. PubMed ID: 18781680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of lipids and lipid signaling in the development of cannabinoid tolerance.
    Martin BR
    Life Sci; 2005 Aug; 77(14):1543-58. PubMed ID: 15949820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between the cannabinoid and dopaminergic systems: evidence from animal studies.
    El Khoury MA; Gorgievski V; Moutsimilli L; Giros B; Tzavara ET
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Jul; 38(1):36-50. PubMed ID: 22300746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cannabinoid-1 receptor is abundantly expressed in striatal striosomes and striosome-dendron bouquets of the substantia nigra.
    Davis MI; Crittenden JR; Feng AY; Kupferschmidt DA; Naydenov A; Stella N; Graybiel AM; Lovinger DM
    PLoS One; 2018; 13(2):e0191436. PubMed ID: 29466446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basic neuroanatomy and neuropharmacology of cannabinoids.
    Breivogel CS; Sim-Selley LJ
    Int Rev Psychiatry; 2009 Apr; 21(2):113-21. PubMed ID: 19367505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striatal cannabinoid CB1 receptor mRNA expression is decreased in the reserpine-treated rat model of Parkinson's disease.
    Silverdale MA; McGuire S; McInnes A; Crossman AR; Brotchie JM
    Exp Neurol; 2001 Jun; 169(2):400-6. PubMed ID: 11358453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and cellular basis of cannabinoid and opioid interactions.
    Viganò D; Rubino T; Parolaro D
    Pharmacol Biochem Behav; 2005 Jun; 81(2):360-8. PubMed ID: 15927245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.